BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s): BVAXF

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.

CSE:BIOV - Post by User

BioVaxys Technology Corp.

<< Previous

Bullboard Posts

Next >>

Post by moneywagonon Oct 07, 2022 2:16pm

87 Views

Post# 35012842

BIOV IT WAS RAYMOND JAMES ON THE BID HE GOT SOME BUT SP TOOK

OFF ON HIM...lol....i had a hunch it was him on that bid! no way he had an order of 500 lol

Recent Trades - Last 10 of 222

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
13:53:52	M	0.195	0.02	250	85 Scotia	80 National Bank
13:53:38	U	0.195	0.02	1,000	1 Anonymous	1 Anonymous	K
13:52:56	H	0.195	0.02	5,000	80 National Bank	1 Anonymous	K
13:52:56	U	0.195	0.02	4,000	80 National Bank	1 Anonymous	K
13:42:15	C	0.19	0.015	500	89 Raymond James	85 Scotia	K
13:20:32	C	0.19	0.015	1,000	89 Raymond James	1 Anonymous	K
13:19:58	C	0.19	0.015	5,000	79 CIBC	1 Anonymous	K
13:19:58	C	0.19	0.015	1,000	89 Raymond James	1 Anonymous	K
13:04:27	C	0.195	0.02	3,000	85 Scotia	7 TD Sec	K
13:04:27	D	0.195	0.02	287	39 Merrill Lynch	7 TD Sec	E